HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Wella first quarter results

This article was originally published in The Rose Sheet

Executive Summary

Cosmetics and fragrance division sales advanced 6.4% to $117.2 mil. (€1=$.91) in first quarter despite weak markets in travel retail and Germany, Darmstadt, Germany company reports. Yardley of London contributed 5.1% to sales growth, yet lowered operating profit due to start-up costs, company noted. Wella acquired Yardley in December (1"The Rose Sheet" Dec. 17, 2001, p. 8). Consumer division sales grew 3.4% to $214.3 mil., slightly below expectations, Wella says. Professional division sales increased 17.3% to $353.7 mil. in Q1, accounting for over half of overall sales. Consolidated sales climbed 10.8% to $685.3 mil., while net profit was up nearly 18% to $21.8 mil. in first quarter...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS010306

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel